Brecon and Quadramed join forces
Leading pharmaceutical outsource provider Brecon Pharmaceuticals Ltd and international regulatory affairs
consultancy QuadraMed Ltd, have formed a partnership to offer their customers a comprehensive clinical trials support service.
Following the introduction of the new EU Clinical Trials Directive in May, pharmaceutical companies carrying out clinical
trials have had to comply with an increasing and often confusing array of new legislation. By establishing the new specialist
partnership, both Brecon's and QuadraMed's customers can now receive a fully comprehensive clinical trials service from a single
point of contact.
Brecon's Head of Clinical Services, Dr Sue Miles, believes the partnership with QuadraMed Ltd provides customers with the best in
support and advice. She said, "There is an increasing demand from our customers for guidance in the completion and submission
of regulatory documentation, translation services or EU legal representation. By establishing this partnership with a specialist
regulatory affairs consultancy such as QuadraMed, we can now offer our customers a specialist and comprehensive service."
Commenting on the partnership, Mr Chris Brooks, Director at QuadraMed Ltd, said, "We are delighted to be working alongside
Brecon Pharmaceuticals as both companies can share and utilise their complementary expertise. On occasion our clients
require analytical services, QP or packaging support, and we can now offer these specialist services through Brecon."
29 July 2021
Back to News Articles